ARTICLE | Clinical News
Enadenotucirev: Phase I/II data
June 2, 2014 7:00 AM UTC
Data from 34 patients with solid tumors of epithelial origin not responding to standard therapy or for whom no standard treatment exists in the Phase I portion of the open-label, dose-escalation, Euro...